Agency Information Collection Activities; Submission for OMB Review; Comment Request; Follow-Up Activities for Product-Related Injuries Including NEISS, 59154-59156 [2021-23302]
Download as PDF
<![CDATA[
59154
Federal Register / Vol. 86, No. 204 / Tuesday, October 26, 2021 / Notices
randomly selected households via a
mailed pre-notification letter, which
were subsequently screened for an inhome or telephone interview, resulted
in an extremely low response rate. To
increase the response rate, the SCOA
survey recruitment effort was
redesigned as a door-to-door walkrecruitment methodology. Field teams
distribute door hangers on randomly
selected households to provide
prenotification that researchers will be
knocking on doors asking for
participation in a survey. A pilot survey
conducted in the Washington metro area
showed significant improvement in the
response rate. Accordingly, to obtain the
best information available, the SCOA
survey data collection will continue to
use this door-to-door recruitment
methodology, recognizing that home
visits by trained data collectors with
inspection and testing provide much
better-quality data compared to
telephone or internet surveys.
Accordingly, the Commission
announces that it has submitted a
request to OMB for approval of renewal
of this collection of information.
Alberta E. Mills,
Secretary, Consumer Product Safety
Commission.
[FR Doc. 2021–23249 Filed 10–25–21; 8:45 am]
BILLING CODE P
CONSUMER PRODUCT SAFETY
COMMISSION
[Docket No. CPSC–2009–0102]
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Follow-Up
Activities for Product-Related Injuries
Including NEISS
Consumer Product Safety
Commission.
ACTION: Notice.
AGENCY:
As required by the Paperwork
Reduction Act of 1995, the Consumer
Product Safety Commission (CPSC or
Commission) announces that the
Commission has submitted to the Office
of Management and Budget (OMB) a
request for extension of approval for an
information collection to obtain data on
consumer product-related injuries, and
follow-up activities for product-related
injuries. OMB previously approved the
collection of information under OMB
Control No. 3041–0029. On July 20,
2021, CPSC published a notice in the
Federal Register to announce the
agency’s intention to seek extension of
approval of the collection of
information. The Commission received
SUMMARY:
VerDate Sep<11>2014
22:39 Oct 25, 2021
Jkt 256001
no comments. Therefore, by publication
of this notice, the Commission
announces that CPSC has submitted to
the OMB a request for extension of
approval of this collection of
information.
DATES: Submit written or electronic
comments on the collection of
information by November 26, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to: www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. In addition, written
comments that are sent to OMB also
should be submitted electronically at:
https://www.regulations.gov, under
Docket No. CPSC–2009–0102.
FOR FURTHER INFORMATION CONTACT: For
further information, or a copy of the
supporting statement, contact: Bretford
Griffin, Consumer Product Safety
Commission, 4330 East West Highway,
Bethesda, MD 20814; (301) 504–7037, or
by email to: bgriffin@cpsc.gov.
SUPPLEMENTARY INFORMATION: On July
20, 2021, CPSC published a notice in
the Federal Register to announce the
agency’s intention to seek approval for
extension of the collection of
information. 86 FR 38316. The
Commission received no comments.
Accordingly, the Commission
announces that it has submitted a
request for approval for renewal of this
collection of information to the OMB.
A. Background
Section 5(a) of the Consumer Product
Safety Act, 15 U.S.C. 2054(a), requires
the CPSC to collect information related
to the causes and prevention of death,
injury, and illness associated with
consumer products. That section also
requires the CPSC to conduct
continuing studies and investigations of
deaths, injuries, diseases, other health
impairments, and economic losses
resulting from accidents involving
consumer products.
The CPSC obtains information about
product-related deaths, injuries, and
illnesses from a variety of sources,
including newspapers, death
certificates, consumer complaints, and
medical facilities. In addition, the CPSC
receives information through its internet
website through forms reporting on
product-related injuries or incidents.
The CPSC also operates the National
Electronic Injury Surveillance System
(NEISS), which provides statistical data
on consumer product-related injuries
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
treated in hospital emergency
departments in the United States. The
CPSC also uses the NEISS system to
collect information on childhood
poisonings, in accordance with the
Poison Prevention Packaging Act of
1970.
From these sources, CPSC staff selects
cases of interest for further
investigation, by contacting persons
who witnessed or were injured in
incidents involving consumer products.
These investigations are conducted onsite (face-to-face), by telephone, or by
the internet. On-site investigations are
usually made in cases where CPSC staff
needs photographs of the incident site,
the product involved, or detailed
information about the incident. This
information can come from face-to-face
interviews with persons who were
injured or who witnessed the incident,
as well as via contact with state and
local officials, including police,
coroners, and fire investigators, and
others with knowledge of the incident.
Through interagency agreements, the
CPSC also uses the NEISS system to
collect information on injuries for the
Centers for Disease Control and
Prevention (CDC) under the NEISS All
Injury Program (NEISS–AIP). The
NEISS–AIP is a sub-sample of
approximately two-thirds of the full
NEISS sample. In addition to the
standard data variables collected on all
NEISS injuries, the NEISS–AIP collects
variables on several studies for CDC
(Firearm-Related Injuries, Adverse Drug
Events, Assaults, Self-Inflicted Violence,
and Work-Related Injuries) and one
study on non-crash, motor vehiclerelated injuries for the National
Highway and Transportation Safety
Administration (NHTSA).
The current NEISS probability sample
was drawn and recruited in 1995–1996,
and implemented in 1997. The current
NEISS sample consists of 96 hospital
emergency departments grouped into
four strata, based on size, as measured
by the annual number of emergency
department (ED) visits, and a fifth
stratum for children’s hospitals. When a
hospital stops participating in the
NEISS, staff recruits a hospital of similar
size and geographic location as a
replacement. If a participating hospital
closes, it is not replaced, because its
closure is presumed to represent other
hospitals that have closed nationally. As
of January 1, 2021, there are currently
81 hospitals participating in the NEISS.
In September 2019, CPSC contracted
with Westat, Inc., under CPSC contract
61320619F0134, to give the agency an
independent statistical assessment of
E:\FR\FM\26OCN1.SGM
26OCN1
59155
Federal Register / Vol. 86, No. 204 / Tuesday, October 26, 2021 / Notices
the NEISS and the NEISS–AIP samples.1
The primary focus of this contract was
to analyze the advantages and
disadvantages of keeping, expanding, or
resampling the current samples of
NEISS and NEISS–AIP hospitals. Westat
recommended that CPSC redesign the
NEISS sample, and, consistent with that
recommendation, CPSC is revising its
sampling methodology.
In the redesigned NEISS sample,
CPSC staff uses a resampling method
that maximizes the probability of
retaining as many of the current NEISS
hospitals as possible, while maintaining
the statistical integrity of the NEISS.
Among eligible hospital emergency
departments, some have migrated from
one stratum to another; others have
come into existence since the last
resampling of the NEISS or ceased to
exist. The method used in resampling
the NEISS is an extension of the Keyfitz
procedures for stratified simple random
samples.2 Staff identified several
advantages of retaining as many of the
current NEISS hospitals as possible,
including: (1) The contracting, datacollection, and quality-control
mechanisms already exist in the
hospitals in the current sample; (2) it is
a cost-effective procedure; and (3) there
is less disruption in trend analysis. The
new NEISS sample will contain a
mixture of current NEISS hospitals,
along with new hospitals recruited to
join the NEISS, as follows:
NEW NEISS SAMPLE
2021 NEISS:
reporting
(retained)
NEISS
redesign
Stratum
2021 NEISS:
reporting
(dropped)
2021 NEISS:
replacements
(retained)
2021 NEISS:
replacements
(dropped)
New
Small ........................................................
Medium ....................................................
Large ........................................................
Very Large ...............................................
Children’s .................................................
43
26
12
11
8
30
14
11
9
7
0
1
8
0
1
8
1
0
2
0
3
0
1
0
0
5
11
1
0
1
Total ..................................................
100
71
10
11
4
18
CPSC recognizes that one of the
advantages of a long-running NEISS
sample is the ability to track trends
across time and updating the NEISS
sample will impact that analysis. An
overlap, or bridge period, during which
data are collected from the old and the
new samples, can adjust for any time
series that crosses over two NEISS
samples. CPSC plans to conduct a 12month overlap as part of the
implementation of the new NEISS
sample. Having a full 12-month overlap
period accounts better for seasonality of
some consumer product-related injuries.
By comparing estimates calculated from
both samples, it is possible to adjust
(backcast) old estimates to be consistent
with the new sample. The overlap
period will consist of all of calendar
year 2023, but it is dependent upon the
successful recruitment of the 11
replacement and 18 new hospitals. If
NEISS hospital recruitment is
successful, the overlap period will run
all of calendar year 2023. The national
estimates for 2023 will be calculated
using the new NEISS sample with
historical estimates from 2022, and prior
years ‘‘backcast’’ to adjust for the
sample update. If NEISS hospital
recruitment is delayed, and the 12month overlap period spans July 2023
through June 2024, then 2023 national
estimates will be calculated using the
old NEISS sample, and 2024 national
estimates would use the new NEISS
sample.
1 David Marker, Jim Green, Frost Hubbord,
Richard Valliant, ‘‘Statistical Assessment of the
NEISS and NEISS–AIP Samples: Final Technical
Report,’’ Westat Inc., September 24, 2020.
2 J. Michael Brick, David R. Morganstein, Charles,
L. Wolter, ‘‘Additional Uses for Keyfitz Selection,’’
Westat Inc., 1987. (https://www.asasrms.org/
Proceedings/papers/1987_140.pdf).
VerDate Sep<11>2014
22:39 Oct 25, 2021
Jkt 256001
B. NEISS Estimated Burden
The NEISS system collects
information on consumer productrelated incidents and other injuries from
a statistical sample of hospitals in the
United States. The number of hospitals
participating in CY 2021 through CY
2024 will fluctuate from the current 81
reporting, to as high as 110.
Respondents to NEISS include
hospitals that directly report
information to NEISS, and hospitals that
allow access to a CPSC contractor who
collects the data. Collecting emergency
department records for review,
correcting error messages, and other
tasks takes from 2.5 to 6 hours weekly.
Each record requires about 30 seconds
to review. Coding and reporting records
that involve consumer products or other
injuries takes about 2 minutes per
record. Coding and reporting on
additional special study information
(Adverse Drug Effects) takes about 2
minutes and 90 seconds per record for
other special studies. Respondents also
spend about 8 to 36 hours per year in
related activities (training, evaluations,
and communicating with other hospital
staff).
During CY 2023, assuming there will
be a total of 110 hospitals participating
in the NEISS, with an estimated 160
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
NEISS respondents (total hospitals and
CPSC contractors), these NEISS
respondents will review an estimated 6
million emergency department records
and report 1.2 million total cases
(470,000 consumer product-related
injuries for CPSC, and 730,000 other
injuries for the NEISS–AIP). The table
below lists the estimated number of
reported cases, and the estimated
number of reported cases with
additional special study information.
Total NEISS cases reported ...............
Consumer Product-Related Injuries ...
CDC NEISS–AIP ................................
1.2 million
470,000
730,000
Special Studies Reported (subset of above)
Child Poisoning (CPSC) .....................
Adverse Drug Events (CDC) ..............
Assaults (CDC) ...................................
Firearm-Related Injuries (CDC) ..........
Self-Inflicted Violence (CDC) ..............
Work-Related Injuries (CDC) ..............
Motor Vehicle Non-Crash Injuries
(NHTSA).
5,000
94,000
84,000
12,000
22,000
54,000
17,000
The total burden hours for all NEISS
respondents are estimated to be 130,000
for CY 2023. The average burden hours
per respondent is 800 hours. However,
the total burden hours on each
respondent varies, due to differences in
the sizes of the hospitals (e.g., small
rural hospitals versus large metropolitan
hospitals). The smallest hospital will
report an estimated 250 cases, with a
burden of about 150 hours; while the
E:\FR\FM\26OCN1.SGM
26OCN1
59156
Federal Register / Vol. 86, No. 204 / Tuesday, October 26, 2021 / Notices
largest hospital will report an estimated
60,000 cases, with a burden of about
4,500 hours.
The total costs to NEISS respondents
for CY 2023 are estimated at $6.5
million. NEISS respondents enter into
contracts with CPSC and are
compensated for these costs. The
average cost per respondent is estimated
to be $41,000. The average cost per
burden hour is estimated to be $50 per
hour (including wages and overhead).
However, the actual cost to each
respondent varies, due to the type of
respondent (hospital versus CPSC
contractor), size of hospital, and
regional differences in wages and
overhead. Therefore, the actual annual
cost for any given respondent may vary
from $3,000 for a small rural hospital,
up to $450,000 for the largest
metropolitan hospital.
C. Other Burden Hours
In cases that require more information
regarding product-related incidents or
injuries, CPSC staff conducts face-toface interviews with approximately 375
persons each year. On average, an onsite interview takes about 4.5 hours.
CPSC staff also conducts about 2,000 indepth investigations (IDIs) by telephone
annually using a Computer Assisted
Telephone Interview (CATI) or selfadministered Computer Assisted
internet Interview (CAII) questionnaires.
Each CATI or CAII IDI requires about 20
minutes. CPSC staff estimates 2,355
annual burden hours on these
respondents: 1,688 hours for face-to-face
interviews; 667 hours for in-depth
telephone or internet interviews. CPSC’s
staff estimates the value of the time
required for reporting is $38.60 an hour
(U.S. Bureau of Labor Statistics,
‘‘Employer Costs for Employee
Compensation,’’ March 2021). At this
valuation, the estimated annual cost to
the public is about $90,903. The cost to
the government for the collection of this
NEISS information is estimated to be
about $8.9 million a year. However, this
estimate includes $6.5 million in
compensation to NEISS respondents, as
described above.
This information collection request
excludes the burden associated with
other publicly available Consumer
Product Safety Information Databases,
such as internet complaints, Hotline,
and Medical Examiners and Coroners
Alert Project (MECAP) reports, which
are approved under OMB control
number 3041–0146. This information
collection request also excludes the
burden associated with follow-up
VerDate Sep<11>2014
22:39 Oct 25, 2021
Jkt 256001
investigations conducted by other
federal agencies.
Alberta E. Mills,
Secretary, Consumer Product Safety
Commission.
[FR Doc. 2021–23302 Filed 10–25–21; 8:45 am]
BILLING CODE 6355–01–P
DELAWARE RIVER BASIN
COMMISSION
Notice of Public Hearing and Business
Meeting; November 10 and December
8, 2021
Notice is hereby given that the
Delaware River Basin Commission will
hold a public hearing on Wednesday,
November 10, 2021. A business meeting
will be held the following month on
Wednesday, December 8, 2021. Both the
hearing and the business meeting are
open to the public. Both meetings will
be conducted remotely. Details about
the remote platform and how to attend
will be posted on the Commission’s
website, www.drbc.gov, on or after
October 29, 2021 for the public hearing
and no later than November 26, 2021 for
the business meeting.
Public Hearing. The Commission will
conduct the public hearing remotely on
November 10, 2021, commencing at 1:30
p.m. Hearing items will include draft
dockets for withdrawals, discharges,
and other projects that could have a
substantial effect on the basin’s water
resources. The list of draft dockets
scheduled for hearing, including project
descriptions, will be posted on the
Commission’s website, www.drbc.gov,
in a long form of this notice at least ten
days before the hearing date.
Written comments on matters
scheduled for hearing on November 10,
2021 will be accepted through 5:00 p.m.
on November 16, 2021.
The public is advised to check the
Commission’s website periodically prior
to the hearing date, as items scheduled
for hearing may be postponed if
additional time is needed to complete
the Commission’s review, and items
may be added up to ten days prior to
the hearing date. In reviewing docket
descriptions, the public is also asked to
be aware that the details of projects may
change during the Commission’s review,
which is ongoing.
Public Meeting. The public business
meeting on December 8, 2021 will begin
at 10:30 a.m. and will include: Adoption
of the Minutes of the Commission’s
September 09, 2021 business meeting;
announcement of upcoming meetings
and events; a report on hydrologic
conditions; reports by the Executive
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Director and the Commission’s General
Counsel; and consideration of any items
for which a hearing has been completed
or is not required.
After all scheduled business has been
completed and as time allows, the
business meeting will be followed by up
to one hour of Open Public Comment,
an opportunity to address the
Commission outside the context of a
duly noticed, on-the-record public
hearing, on any topic concerning
management of the Basin’s water
resources.
There will be no opportunity for
additional public comment for the
record at the December 8 business
meeting on items for which a hearing
was completed on November 10 or a
previous date. Commission
consideration on December 8 of items
for which the public hearing is closed
may result in approval of the item (by
docket or resolution) as proposed,
approval with changes, denial, or
deferral. When the Commissioners defer
an action, they may announce an
additional period for written comment
on the item, with or without an
additional hearing date, or they may
take additional time to consider the
input they have already received
without requesting further public input.
Any deferred items will be considered
for action at a public meeting of the
Commission on a future date.
Advance Sign-Up for Oral Comment.
Individuals who wish to comment on
the record during the public hearing on
November 10 or to address the
Commissioners informally during the
Open Public Comment portion of the
meeting on December 8 are asked to sign
up in advance through EventBrite. Links
to EventBrite for the public hearing and
the business meeting will be available at
www.drbc.gov at least 10 days before the
public hearing. For assistance, please
contact Ms. Patricia Hausler of the
Commission staff, at patricia.hausler@
drbc.gov.
Submitting Written Comment. Written
comment on items scheduled for
hearing may be made through the
Commission’s web-based comment
system, a link to which is provided at
www.drbc.gov. Use of the web-based
system ensures that all submissions are
captured in a single location and their
receipt is acknowledged. Exceptions to
the use of this system are available
based on need, by writing to the
attention of the Commission Secretary,
DRBC, P.O. Box 7360, 25 Cosey Road,
West Trenton, NJ 08628–0360. For
assistance in using the web-based
comment system, please contact Patricia
Hausler of the Commission staff, at
patricia.hausler@drbc.gov.
E:\FR\FM\26OCN1.SGM
26OCN1
]]>Agencies
[Federal Register Volume 86, Number 204 (Tuesday, October 26, 2021)]
[Notices]
[Pages 59154-59156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23302]
-----------------------------------------------------------------------
CONSUMER PRODUCT SAFETY COMMISSION
[Docket No. CPSC-2009-0102]
Agency Information Collection Activities; Submission for OMB
Review; Comment Request; Follow-Up Activities for Product-Related
Injuries Including NEISS
AGENCY: Consumer Product Safety Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As required by the Paperwork Reduction Act of 1995, the
Consumer Product Safety Commission (CPSC or Commission) announces that
the Commission has submitted to the Office of Management and Budget
(OMB) a request for extension of approval for an information collection
to obtain data on consumer product-related injuries, and follow-up
activities for product-related injuries. OMB previously approved the
collection of information under OMB Control No. 3041-0029. On July 20,
2021, CPSC published a notice in the Federal Register to announce the
agency's intention to seek extension of approval of the collection of
information. The Commission received no comments. Therefore, by
publication of this notice, the Commission announces that CPSC has
submitted to the OMB a request for extension of approval of this
collection of information.
DATES: Submit written or electronic comments on the collection of
information by November 26, 2021.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to: www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. In
addition, written comments that are sent to OMB also should be
submitted electronically at: https://www.regulations.gov, under Docket
No. CPSC-2009-0102.
FOR FURTHER INFORMATION CONTACT: For further information, or a copy of
the supporting statement, contact: Bretford Griffin, Consumer Product
Safety Commission, 4330 East West Highway, Bethesda, MD 20814; (301)
504-7037, or by email to: [email protected].
SUPPLEMENTARY INFORMATION: On July 20, 2021, CPSC published a notice in
the Federal Register to announce the agency's intention to seek
approval for extension of the collection of information. 86 FR 38316.
The Commission received no comments. Accordingly, the Commission
announces that it has submitted a request for approval for renewal of
this collection of information to the OMB.
A. Background
Section 5(a) of the Consumer Product Safety Act, 15 U.S.C. 2054(a),
requires the CPSC to collect information related to the causes and
prevention of death, injury, and illness associated with consumer
products. That section also requires the CPSC to conduct continuing
studies and investigations of deaths, injuries, diseases, other health
impairments, and economic losses resulting from accidents involving
consumer products.
The CPSC obtains information about product-related deaths,
injuries, and illnesses from a variety of sources, including
newspapers, death certificates, consumer complaints, and medical
facilities. In addition, the CPSC receives information through its
internet website through forms reporting on product-related injuries or
incidents. The CPSC also operates the National Electronic Injury
Surveillance System (NEISS), which provides statistical data on
consumer product-related injuries treated in hospital emergency
departments in the United States. The CPSC also uses the NEISS system
to collect information on childhood poisonings, in accordance with the
Poison Prevention Packaging Act of 1970.
From these sources, CPSC staff selects cases of interest for
further investigation, by contacting persons who witnessed or were
injured in incidents involving consumer products. These investigations
are conducted on-site (face-to-face), by telephone, or by the internet.
On-site investigations are usually made in cases where CPSC staff needs
photographs of the incident site, the product involved, or detailed
information about the incident. This information can come from face-to-
face interviews with persons who were injured or who witnessed the
incident, as well as via contact with state and local officials,
including police, coroners, and fire investigators, and others with
knowledge of the incident.
Through interagency agreements, the CPSC also uses the NEISS system
to collect information on injuries for the Centers for Disease Control
and Prevention (CDC) under the NEISS All Injury Program (NEISS-AIP).
The NEISS-AIP is a sub-sample of approximately two-thirds of the full
NEISS sample. In addition to the standard data variables collected on
all NEISS injuries, the NEISS-AIP collects variables on several studies
for CDC (Firearm-Related Injuries, Adverse Drug Events, Assaults, Self-
Inflicted Violence, and Work-Related Injuries) and one study on non-
crash, motor vehicle-related injuries for the National Highway and
Transportation Safety Administration (NHTSA).
The current NEISS probability sample was drawn and recruited in
1995-1996, and implemented in 1997. The current NEISS sample consists
of 96 hospital emergency departments grouped into four strata, based on
size, as measured by the annual number of emergency department (ED)
visits, and a fifth stratum for children's hospitals. When a hospital
stops participating in the NEISS, staff recruits a hospital of similar
size and geographic location as a replacement. If a participating
hospital closes, it is not replaced, because its closure is presumed to
represent other hospitals that have closed nationally. As of January 1,
2021, there are currently 81 hospitals participating in the NEISS.
In September 2019, CPSC contracted with Westat, Inc., under CPSC
contract 61320619F0134, to give the agency an independent statistical
assessment of
[[Page 59155]]
the NEISS and the NEISS-AIP samples.\1\ The primary focus of this
contract was to analyze the advantages and disadvantages of keeping,
expanding, or resampling the current samples of NEISS and NEISS-AIP
hospitals. Westat recommended that CPSC redesign the NEISS sample, and,
consistent with that recommendation, CPSC is revising its sampling
methodology.
---------------------------------------------------------------------------
\1\ David Marker, Jim Green, Frost Hubbord, Richard Valliant,
``Statistical Assessment of the NEISS and NEISS-AIP Samples: Final
Technical Report,'' Westat Inc., September 24, 2020.
---------------------------------------------------------------------------
In the redesigned NEISS sample, CPSC staff uses a resampling method
that maximizes the probability of retaining as many of the current
NEISS hospitals as possible, while maintaining the statistical
integrity of the NEISS. Among eligible hospital emergency departments,
some have migrated from one stratum to another; others have come into
existence since the last resampling of the NEISS or ceased to exist.
The method used in resampling the NEISS is an extension of the Keyfitz
procedures for stratified simple random samples.\2\ Staff identified
several advantages of retaining as many of the current NEISS hospitals
as possible, including: (1) The contracting, data-collection, and
quality-control mechanisms already exist in the hospitals in the
current sample; (2) it is a cost-effective procedure; and (3) there is
less disruption in trend analysis. The new NEISS sample will contain a
mixture of current NEISS hospitals, along with new hospitals recruited
to join the NEISS, as follows:
---------------------------------------------------------------------------
\2\ J. Michael Brick, David R. Morganstein, Charles, L. Wolter,
``Additional Uses for Keyfitz Selection,'' Westat Inc., 1987.
(https://www.asasrms.org/Proceedings/papers/1987_140.pdf).
New NEISS Sample
--------------------------------------------------------------------------------------------------------------------------------------------------------
2021 NEISS: 2021 NEISS: 2021 NEISS: 2021 NEISS:
Stratum NEISS redesign reporting reporting replacements replacements New
(retained) (dropped) (retained) (dropped)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Small................................................... 43 30 0 8 3 5
Medium.................................................. 26 14 1 1 0 11
Large................................................... 12 11 8 0 1 1
Very Large.............................................. 11 9 0 2 0 0
Children's.............................................. 8 7 1 0 0 1
-----------------------------------------------------------------------------------------------
Total............................................... 100 71 10 11 4 18
--------------------------------------------------------------------------------------------------------------------------------------------------------
CPSC recognizes that one of the advantages of a long-running NEISS
sample is the ability to track trends across time and updating the
NEISS sample will impact that analysis. An overlap, or bridge period,
during which data are collected from the old and the new samples, can
adjust for any time series that crosses over two NEISS samples. CPSC
plans to conduct a 12-month overlap as part of the implementation of
the new NEISS sample. Having a full 12-month overlap period accounts
better for seasonality of some consumer product-related injuries. By
comparing estimates calculated from both samples, it is possible to
adjust (backcast) old estimates to be consistent with the new sample.
The overlap period will consist of all of calendar year 2023, but it is
dependent upon the successful recruitment of the 11 replacement and 18
new hospitals. If NEISS hospital recruitment is successful, the overlap
period will run all of calendar year 2023. The national estimates for
2023 will be calculated using the new NEISS sample with historical
estimates from 2022, and prior years ``backcast'' to adjust for the
sample update. If NEISS hospital recruitment is delayed, and the 12-
month overlap period spans July 2023 through June 2024, then 2023
national estimates will be calculated using the old NEISS sample, and
2024 national estimates would use the new NEISS sample.
B. NEISS Estimated Burden
The NEISS system collects information on consumer product-related
incidents and other injuries from a statistical sample of hospitals in
the United States. The number of hospitals participating in CY 2021
through CY 2024 will fluctuate from the current 81 reporting, to as
high as 110.
Respondents to NEISS include hospitals that directly report
information to NEISS, and hospitals that allow access to a CPSC
contractor who collects the data. Collecting emergency department
records for review, correcting error messages, and other tasks takes
from 2.5 to 6 hours weekly. Each record requires about 30 seconds to
review. Coding and reporting records that involve consumer products or
other injuries takes about 2 minutes per record. Coding and reporting
on additional special study information (Adverse Drug Effects) takes
about 2 minutes and 90 seconds per record for other special studies.
Respondents also spend about 8 to 36 hours per year in related
activities (training, evaluations, and communicating with other
hospital staff).
During CY 2023, assuming there will be a total of 110 hospitals
participating in the NEISS, with an estimated 160 NEISS respondents
(total hospitals and CPSC contractors), these NEISS respondents will
review an estimated 6 million emergency department records and report
1.2 million total cases (470,000 consumer product-related injuries for
CPSC, and 730,000 other injuries for the NEISS-AIP). The table below
lists the estimated number of reported cases, and the estimated number
of reported cases with additional special study information.
------------------------------------------------------------------------
------------------------------------------------------------------------
Total NEISS cases reported................. 1.2 million
Consumer Product-Related Injuries.......... 470,000
CDC NEISS-AIP.............................. 730,000
------------------------------------------------------------------------
Special Studies Reported (subset of above)
------------------------------------------------------------------------
Child Poisoning (CPSC)..................... 5,000
Adverse Drug Events (CDC).................. 94,000
Assaults (CDC)............................. 84,000
Firearm-Related Injuries (CDC)............. 12,000
Self-Inflicted Violence (CDC).............. 22,000
Work-Related Injuries (CDC)................ 54,000
Motor Vehicle Non-Crash Injuries (NHTSA)... 17,000
------------------------------------------------------------------------
The total burden hours for all NEISS respondents are estimated to
be 130,000 for CY 2023. The average burden hours per respondent is 800
hours. However, the total burden hours on each respondent varies, due
to differences in the sizes of the hospitals (e.g., small rural
hospitals versus large metropolitan hospitals). The smallest hospital
will report an estimated 250 cases, with a burden of about 150 hours;
while the
[[Page 59156]]
largest hospital will report an estimated 60,000 cases, with a burden
of about 4,500 hours.
The total costs to NEISS respondents for CY 2023 are estimated at
$6.5 million. NEISS respondents enter into contracts with CPSC and are
compensated for these costs. The average cost per respondent is
estimated to be $41,000. The average cost per burden hour is estimated
to be $50 per hour (including wages and overhead). However, the actual
cost to each respondent varies, due to the type of respondent (hospital
versus CPSC contractor), size of hospital, and regional differences in
wages and overhead. Therefore, the actual annual cost for any given
respondent may vary from $3,000 for a small rural hospital, up to
$450,000 for the largest metropolitan hospital.
C. Other Burden Hours
In cases that require more information regarding product-related
incidents or injuries, CPSC staff conducts face-to-face interviews with
approximately 375 persons each year. On average, an on-site interview
takes about 4.5 hours. CPSC staff also conducts about 2,000 in-depth
investigations (IDIs) by telephone annually using a Computer Assisted
Telephone Interview (CATI) or self-administered Computer Assisted
internet Interview (CAII) questionnaires. Each CATI or CAII IDI
requires about 20 minutes. CPSC staff estimates 2,355 annual burden
hours on these respondents: 1,688 hours for face-to-face interviews;
667 hours for in-depth telephone or internet interviews. CPSC's staff
estimates the value of the time required for reporting is $38.60 an
hour (U.S. Bureau of Labor Statistics, ``Employer Costs for Employee
Compensation,'' March 2021). At this valuation, the estimated annual
cost to the public is about $90,903. The cost to the government for the
collection of this NEISS information is estimated to be about $8.9
million a year. However, this estimate includes $6.5 million in
compensation to NEISS respondents, as described above.
This information collection request excludes the burden associated
with other publicly available Consumer Product Safety Information
Databases, such as internet complaints, Hotline, and Medical Examiners
and Coroners Alert Project (MECAP) reports, which are approved under
OMB control number 3041-0146. This information collection request also
excludes the burden associated with follow-up investigations conducted
by other federal agencies.
Alberta E. Mills,
Secretary, Consumer Product Safety Commission.
[FR Doc. 2021-23302 Filed 10-25-21; 8:45 am]
BILLING CODE 6355-01-P
